These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 25565817
1. Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78. Zhao L, Li H, Shi Y, Wang G, Liu L, Su C, Su R. Int J Nanomedicine; 2015; 10():245-56. PubMed ID: 25565817 [Abstract] [Full Text] [Related]
2. GRP78 Regulates Apoptosis, Cell Survival and Proliferation in 5-Fluorouracil-resistant SNUC5 Colon Cancer Cells. Lee JH, Yoon YM, Lee SH. Anticancer Res; 2017 Sep; 37(9):4943-4951. PubMed ID: 28870916 [Abstract] [Full Text] [Related]
3. SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy. Ma X, Cheng Z, Jin Y, Liang X, Yang X, Dai Z, Tian J. Biomaterials; 2014 Mar; 35(9):2878-89. PubMed ID: 24411331 [Abstract] [Full Text] [Related]
7. Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer? Delie F, Ribaux P, Petignat P, Cohen M. Biochimie; 2012 Nov; 94(11):2391-7. PubMed ID: 22713763 [Abstract] [Full Text] [Related]
8. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44. Wang T, Hou J, Su C, Zhao L, Shi Y. J Nanobiotechnology; 2017 Jan 10; 15(1):7. PubMed ID: 28068992 [Abstract] [Full Text] [Related]
9. The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M. Zhao S, Li H, Wang Q, Su C, Wang G, Song H, Zhao L, Luan Z, Su R. BMC Cancer; 2015 May 10; 15():389. PubMed ID: 25958313 [Abstract] [Full Text] [Related]
10. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J, Li J, Shi Z, Yang Y, Xie X, Lee SM, Wang Y, Leong KW, Chen M. Acta Biomater; 2017 Aug 10; 58():349-364. PubMed ID: 28455219 [Abstract] [Full Text] [Related]
11. Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma. Chiou JF, Tai CJ, Huang MT, Wei PL, Wang YH, An J, Wu CH, Liu TZ, Chang YJ. Ann Surg Oncol; 2010 Feb 10; 17(2):603-12. PubMed ID: 19830497 [Abstract] [Full Text] [Related]
12. Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma. Chang YJ, Tai CJ, Kuo LJ, Wei PL, Liang HH, Liu TZ, Wang W, Tai CJ, Ho YS, Wu CH, Huang MT. Ann Surg Oncol; 2011 Aug 10; 18(8):2395-403. PubMed ID: 21347788 [Abstract] [Full Text] [Related]
13. GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinoma. Gu YJ, Li HD, Zhao L, Zhao S, He WB, Rui L, Su C, Zheng HC, Su RJ. Oncotarget; 2015 Oct 20; 6(32):33658-74. PubMed ID: 26378040 [Abstract] [Full Text] [Related]
14. Prospective impact of 5-FU in the induction of endoplasmic reticulum stress, modulation of GRP78 expression and autophagy in Sk-Hep1 cells. Yadunandam AK, Yoon JS, Seong YA, Oh CW, Kim GD. Int J Oncol; 2012 Sep 20; 41(3):1036-42. PubMed ID: 22684338 [Abstract] [Full Text] [Related]
15. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells. Li R, Yanjiao G, Wubin H, Yue W, Jianhua H, Huachuan Z, Rongjian S, Zhidong L. Oncotarget; 2017 Mar 21; 8(12):19354-19364. PubMed ID: 28423613 [Abstract] [Full Text] [Related]
16. Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma. Yip CW, Lam CY, Poon TCW, Cheung TT, Cheung PFY, Fung SW, Wang XQ, Leung ICY, Ng LWC, Lo CM, Tsao GSW, Cheung ST. BMC Cancer; 2017 Jun 10; 17(1):409. PubMed ID: 28601093 [Abstract] [Full Text] [Related]
17. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H. Cell Death Differ; 2004 Jul 10; 11 Suppl 1():S86-96. PubMed ID: 15105837 [Abstract] [Full Text] [Related]
18. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Varshney A, Panda JJ, Singh AK, Yadav N, Bihari C, Biswas S, Sarin SK, Chauhan VS. Hepatology; 2018 Apr 10; 67(4):1392-1407. PubMed ID: 29108133 [Abstract] [Full Text] [Related]
19. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice. Nasr M, Nafee N, Saad H, Kazem A. Eur J Pharm Biopharm; 2014 Sep 10; 88(1):216-25. PubMed ID: 24813390 [Abstract] [Full Text] [Related]
20. GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy. Jiang B, Zhang R, Zhang J, Hou Y, Chen X, Zhou M, Tian X, Hao C, Fan K, Yan X. Theranostics; 2019 Sep 10; 9(8):2167-2182. PubMed ID: 31149036 [Abstract] [Full Text] [Related] Page: [Next] [New Search]